.jpg?format=webp&width=780)
In patients with severe tricuspid regurgitation, percutaneous tricuspid transcatheter edge-to-edge repair (TEER) is associated with an improvement in quality of life and a reduction in disease severity compared with medical therapy. These findings from the randomized TRILUMINATE Pivotal trial were presented at ACC.23.
Like
Save
Share